Research

How should we be defining a meaningful clinical response to TNF-blockers in ankylosing spondylitis patients?


Reference:

Stone, M., Cortinovis, D., Raj, A. G., Maetzel, A., Inman, R., Lapp, V. and Beaton, D., 2006. How should we be defining a meaningful clinical response to TNF-blockers in ankylosing spondylitis patients? Annals of the Rheumatic Diseases, 65, p. 544.

Related documents:

This repository does not currently have the full-text of this item.
You may be able to access a copy if URLs are provided below.

Details

Item Type Articles
CreatorsStone, M., Cortinovis, D., Raj, A. G., Maetzel, A., Inman, R., Lapp, V. and Beaton, D.
DepartmentsFaculty of Humanities & Social Sciences > Health
Faculty of Science > Pharmacy & Pharmacology
RefereedYes
StatusPublished
ID Code6374
Additional InformationID number: ISI:000249372502252

Export

Actions (login required)

View Item